Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Lorenzon (BUENOS AIRES, Argentina). Prevalence and phenotype of subjects carrying rare variants in Argentina for alpha1-antitrypsin deficiency. 966

Member's Comments

No comment yet.

Related content which might interest you: Clinical phenotype of individuals with common COPD investigated during the targeted detection programme for alpha1-antitrypsin deficiency in Italy Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Characterization of a population of alpha1-antitrypsin deficient (A1ATD) patients Source: Annual Congress 2008 - COPD Year: 2008 Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Rare SERPINA1 allele Mwhitstable in patients with Alpha1-antitrypsin deficiency Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Tracing down the evolutionary history of Q0Ourém, a rare allele associated with severe alpha-1-antitrypsin deficiency (AATD) Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Prevalence of mannose-binding lectin variant alleles among cystic fibrosis patients in Italy Source: Eur Respir J 2002; 20: Suppl. 38, 339s Year: 2002 Estimated numbers and prevalence of PI*S and PI*Z alleles of α1-antitrypsin deficiency in European countries Source: Eur Respir J 2006; 27: 77-84 Year: 2006 Estimates of the prevalence of alpha-1 antitrypsin deficiency PI*S and PI*Z alleles and the numbers at risk in Europe Source: Eur Respir J 2005; 26: Suppl. 49, 219s Year: 2005 Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 M2 allele of alpha1-antitrypsin gene and genetic susceptibility to COPD in Korean men Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 a1-antitrypsin PI*SZ genotype: a SERPINA1 deficiency haplotype with uncertain clinical and therapeutic implications Source: Eur Respir J, 55 (6) 2000713; 10.1183/13993003.00713-2020 Year: 2020 Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of α1-antitrypsin deficiency in Asia Source: Eur Respir J 2006; 28: 1091-1099 Year: 2006 SERPINA1 gene variants in subjects from a general population with reduced alpha1-antitrypsin level Source: Annual Congress 2008 - COPD Year: 2008 Does urinary peptide content differ between COPD patients with and without inherited alpha1-antitrypsin deficiency? Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020 Year: 2020